Key points are not available for this paper at this time.
No takes yet. Share an insight, caveat, or question.
Alerts clinicians to potential glucose monitor accuracy issues; leaves open adequacy of post-approval surveillance.
Klonoff et al. (2013) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: